¹ PMID: 19254969; https://doi.org/10.1155/2020/1834534; https://doi.org/10.1007/s00125-021-05396-5; PMID: 26649106; PMID: 34790639
² https://doi.org/10.1002/edm2.379; https://doi.org/10.2337/dci21-0043; 12 week measurements compared to study baselines
³ Reported time <50mg/dL across all subjects over 12 weeks: average of 0.78% and median of 0.21% time spent in hypoglycemia
⁴ ML prediction up to a 120 minute horizon and accuracy per point measurement at 76.8% ±4.2%
bioX is an investigational solution limited by Swiss law to investigational use. Not available for sale. To be clear, bioX is not yet commercially available because it has not yet been cleared by the MDR or FDA or any other regulatory body. We will have to obtain regulatory clearances before we can offer it for commercial sale.
OneTwenty and bioX are registered trademarks of OneTwenty AG. Other trademarks are the property of their respective owners. No use of any OneTwenty AG trademark, trade name, or trade dress in this site may be made without the prior written authorisation of OneTwenty AG, except to identify the product or services of the company. The product images are for illustrative purposes only.